CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 320 enrolled
Drug / intervention
Standard of Care +1 moredrug
Likely dose
TDF + 3TC (or FTC) + EFV as a fixed-dose combination twice dailyAI-extracted
Key inclusion· 2
  • Patients: age ≥18 years, HIV-infected, newly enrolled in ART at Namacurra Sede
  • Traditional Healers: age ≥18 years, living within 10 km of clinic, previously trained by FGH, speak Portuguese, see ≥1 patient/month
Key exclusion· 2
  • Patients: currently pregnant, HIV-uninfected, not enrolled in HIV care, or unable to consent due to mental limitations or intoxication
  • Traditional Healers: those who believe they can effectively treat or cure HIV or associated conditions

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03076359
NCT03076359N/ACompleted

Traditional Healers as Adherence Partners for PLHIV in Rural Mozambique

Vanderbilt University Medical Center·interventional·Posted Mar 10, 2017·Updated Sep 29, 2020

In Brief

A clinical study evaluating Traditional Healer Support Program and Standard of Care for HIV/AIDS. Completed, enrolled 320 participants across 1 site.

Detailed Summary

The overall goal of this project is to adapt and assess the impact of a traditional healer training program/intervention on the adherence, retention, and viral load of HIV infected patients newly initiated on anti-retroviral therapy in rural Mozambique.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV/AIDS
CountriesMozambique

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 10, 2017
Enrollment StartJun 10, 2015
Primary CompletionMay 30, 2019
Study CompletionJun 30, 2019
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 9.3 years ago

Interventions

Traditional Healer Support Programbehavioral

Traditional Healers will provide the "traditional healer support program" assistance, as previously described, to all newly diagnosed patients.

Standard of Caredrug

First-line ART will consist of two nucleoside reverse-transcriptase inhibitors (NRTIs) plus a non-nucleoside reverse-transcriptase inhibitor (NNRTI)- TDF + 3TC (or FTC) + EFV as a fixed-dose combination to be taken twice a day for the rest of the patient's life), clinic-based counseling, and community searches if lost to follow up.